The clinical management of persistent moderate-to-severe pain remains one of the most complex responsibilities in modern medicine. For generations, traditional full mu-opioid receptor agonists have served as the cornerstone of analgesic intervention; however, their extensive use is frequently complicated by severe physiological drawbacks, including rapid tolerance development, physical dependence, respiratory suppression, and high potential for […]